Evidence map›Paper›PMID 40237527›Full record

ArticlemSystems2025

Decoding cancer prognosis with deep learning: the ASD-cancer framework for tumor microenvironment analysis.

Ziyuan Huang, Yunzhan Li, Vanni Bucci, John P Haran

Abstract readComment
In one paragraph

Article in mSystems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Ziyuan HuangDepartment of Emergency Medicine, UMass Chan Medical School, Worcester, Massachusetts, USA.ORCID 0000-0002-2215-2473
Yunzhan LiDepartment of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Vanni BucciDepartment of Microbiology, UMass Chan Medical School, Worcester, Massachusetts, USA.
John P HaranDepartment of Emergency Medicine, UMass Chan Medical School, Worcester, Massachusetts, USA.ORCID 0000-0001-7311-1121

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep learning is revolutionizing biomedical research by facilitating the integration of multi-omics data sets while bridging classical bioinformatics with existing knowledge. Building on this powerful potential, Zhang et al. proposed a semi-supervised learning framework called Autoencoder-Based Subtypes Detector for Cancer (ASD-cancer) to improve the multi-omics data analysis (H. Zhang, X. Xiong, M. Cheng, et al., 2024, mSystems 9:e01395-24, https://doi.org/10.1128/msystems.01395-24). By utilizing autoencoders pre-trained on The Cancer Genome Atlas data, the ASD-cancer framework outperforms the baseline model. This approach also makes the framework scalable, enabling it to process new data sets through transfer learning without retraining. This commentary explores the methodological innovations and scalability of ASD-cancer while suggesting future directions, such as the incorporation of additional data layers and the development of adaptive AI models through continuous learning. Notably, integrating large language models into ASD-cancer could enhance its interpretability, providing more profound insights into oncological research and increasing its influence in cancer subtyping and further analysis.

Indexed as

Deep LearningNeoplasmsTumor MicroenvironmentComputational BiologyHumansPrognosisautoencodercancer prognosisdeep learningmulti-omicstransfer learning

Identifiers

PMID40237527
PMCPMC12090842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.